Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.

K, Aogi; H, Takeuchi; T, Saeki; K, Aiba; K, Tamura; K, Iino; CK, Imamura; K, Okita; Y, Kagami; R, Tanaka; K, Nakagawa; H, Fujii; N, Boku; M, Wada; T, Akechi; H, Iihara; S, Ohtani; A, Okuyama; K, Ozawa; YI, Kim; H, Sasaki; Y, Shima; M, Takeda; E, Nagasaki; T, Nishidate; T, Higashi; K, Hirata

doi:10.1007/s10147-020-01818-3

Public

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.

Shared by NobleBlocks on Nov 8, 2020 • 12:00 AM UTC

Authors:

Aogi K

Takeuchi H

Saeki T

Abstract

Patients with cancer should appropriately receive antiemetic therapies against chemotherapy-induced nausea and vomiting (CINV). Antiemetic guidelines play an important role in managing CINV. Accordingly, the first Japanese antiemetic guideline published in 2010 by the Japan Society of Clinical Oncol...

Subject

Clinical Practice Guideline

Chemotherapy-induced Nausea And Vomiting

Antiemesis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!